What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.86%Above 5Y avg (0.71%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
57.9%Sustainable
Payback Period
88.9 yr
Last Ex-Dividend
Apr 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.60BCNY
688.95M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
67.18x
Updated Oct 21, 2026
Revenue (TTM)
775.15MCNY
116.12M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
8.82%
Updated Oct 21, 2026
Beta
0.0990x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-3.63%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
4.60BCNY
688.95M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
3.99BCNY
598.30M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
67.18x
Updated Oct 21, 2026
Forward P/E
17.76x
Updated Oct 21, 2026
Price to Sales (TTM)
5.83x
Updated Oct 21, 2026
Price to Book (MRQ)
3.51x
Updated Oct 21, 2026
Enterprise to Revenue
5.15x
Updated Oct 21, 2026
Enterprise to EBITDA
55.26x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 30.89×.Updated Oct 21, 2026
Gross Margin
29.45%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 25.87%.Updated Oct 21, 2026
Profit Margin
8.82%
Updated Oct 21, 2026
Return on Assets (TTM)
2.91%
Updated Oct 21, 2026
Return on Equity (TTM)
4.99%
Updated Oct 21, 2026
Revenue (TTM)
775.15MCNY
116.12M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
1.95CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
-36.10%
Updated Oct 21, 2026
Gross Profit (TTM)
200.52MCNY
30.04M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
129.29MCNY
19.37M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
68.33MCNY
10.24M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
64.67%
Updated Oct 21, 2026
Operating Cash Flow (TTM)
76.71MCNY
11.49M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
13.15MCNY
1.97M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.1000CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
0.86%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.71%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
57.88%
Updated Oct 21, 2026
Minority Interest (Equity)
27.85MCNYFY2025 · Dec 31, 2025
Revenue
824.95MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
575.06MCNYFY2025 · Dec 31, 2025
Gross Profit
249.88MCNYFY2025 · Dec 31, 2025
Operating Income
92.01MCNY
13.78M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
70.38MCNYFY2025 · Dec 31, 2025
Income Tax Expense
3.65MCNYFY2025 · Dec 31, 2025
Net Income
66.73MCNYFY2025 · Dec 31, 2025
EBIT
71.39MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
129.29MCNYFY2025 · Dec 31, 2025
Research & Development
72.95MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
12.80MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
5.45MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
278.89KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.00MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1879CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1871CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
393.80MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
393.80MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
66.73MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
7.25MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
4.26MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-47.50MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
525.20MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
66.73MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
3.71MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-19.11MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-47.07MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-51.77MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-514.70MCNYFY2025 · Dec 31, 2025
Sale of Investments
462.39MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-104.08MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
249.28MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-30.10MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-4.65MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
214.53MCNYFY2025 · Dec 31, 2025
Shares Outstanding
395.79MSharesUpdated Oct 21, 2026
Float Shares
246.19MSharesUpdated Oct 21, 2026
% Held by Insiders
39.11%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
0.45%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
736.60MCNY
110.34M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
1.86CNYUpdated Oct 21, 2026
Total Debt (MRQ)
263.59MCNY
39.49M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.2011x
Updated Oct 21, 2026
Current Ratio (MRQ)
6.93x
Updated Oct 21, 2026
Book Value per Share (MRQ)
3.25CNYUpdated Oct 21, 2026
Total Assets
1.89BCNY
282.78M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.62BCNYFY2025 · Dec 31, 2025
Total Liabilities
542.16MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
266.52MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
247.17MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
294.99MCNYFY2025 · Dec 31, 2025
Cash
455.75MCNYFY2025 · Dec 31, 2025
Cash Equivalents
7.28MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
463.02MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
380.78MCNYFY2025 · Dec 31, 2025
Accounts Receivable
541.97MCNYFY2025 · Dec 31, 2025
Inventory
106.34MCNYFY2025 · Dec 31, 2025
Accounts Payable
61.80MCNYFY2025 · Dec 31, 2025
Short-term Debt
17.13MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.02MCNYFY2025 · Dec 31, 2025
Long-term Debt
244.60MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
282.78MCNYFY2025 · Dec 31, 2025
Retained Earnings
564.89MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.35BCNY
201.56M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
3.89MCNYFY2025 · Dec 31, 2025
52-Week Low
10.27CNYUpdated Oct 21, 2026
52-Week High
20.93CNYUpdated Oct 21, 2026
52-Week Change
-3.63%
vs all stocks
Updated Oct 21, 2026
Beta
0.0990x
vs all stocks
Updated Oct 21, 2026
50-Day MA
13.51CNYUpdated Oct 21, 2026
200-Day MA
12.73CNYUpdated Oct 21, 2026
Avg 10-Day Volume
13.18MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
17.88MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.1700CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.91: safe zoneNotable
Altman Z-Score: 6.91
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.